Product Program year 2025 Source: CMS Open Payments

Wayrilz

Drug Immunology

NDC 58468-0251-6

Open in the dashboard

General payments

$541,166

2,915 payments

Research payments

$1,477,530

280 payments

Through program year 2025, $541,166 in general payments and $1,477,530 in research payments were reported against Wayrilz (Immunology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $541,166 2,915
2025 Research $1,477,530 280

Breakdown

Who paid General payments · program year 2025
  1. Genzyme Corporation $532,503 2,909 payments
  2. Sanofi US Services Inc. $5,196 5 payments
  3. Sanofi Pasteur Inc. $3,466 1 payment
Top recipients General payments · program year 2025
  1. Asad Dean Hematology & Oncology · Fort Worth, TX $69,048 13% · 41 payments
  2. Michael Tarantino Pediatric Hematology-Oncology · Peoria, IL $68,699 13% · 26 payments
  3. Amit Mehta Hematology & Oncology · Cary, NC $49,647 9% · 30 payments
  4. Trevor Feinstein Hematology & Oncology · Fayetteville, GA $42,758 8% · 23 payments
  5. Jamie Koprivnikar Medical Oncology · Hackensack, NJ $24,415 5% · 12 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Hematology & Oncology Internal Medicine $284,775 55% · 654 practitioners
  2. Pediatric Hematology-Oncology Pediatrics $87,996 17% · 32 practitioners
  3. Medical Oncology Internal Medicine $34,371 7% · 158 practitioners
  4. Physician Assistant $22,480 4% · 209 practitioners
  5. Hematology Internal Medicine $18,596 4% · 31 practitioners

The top 5 of 64 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $100,251 19% · 184 recipients
  2. Illinois $70,309 13% · 52 recipients
  3. North Carolina $52,458 10% · 48 recipients
  4. Georgia $46,526 9% · 99 recipients
  5. California $44,372 8% · 288 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

2,915 general · 280 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record